BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19863162)

  • 1. Phosphatidyl choline-based colloidal systems for dermal and transdermal drug delivery.
    Ferderber K; Hook S; Rades T
    J Liposome Res; 2009; 19(4):267-77. PubMed ID: 19863162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal delivery of hydrophobic and hydrophilic local anesthetics from o/w and w/o Brij 97-based microemulsions.
    Junyaprasert VB; Boonme P; Songkro S; Krauel K; Rades T
    J Pharm Pharm Sci; 2007; 10(3):288-98. PubMed ID: 17727792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative formulations for the delivery of levothyroxine to the skin.
    Padula C; Nicoli S; Santi P
    Int J Pharm; 2009 May; 372(1-2):12-6. PubMed ID: 19162148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermal delivery of selected hydrophilic drugs from elastic liposomes: effect of phospholipid formulation and surfactants.
    Ita KB; Du Preez J; Lane ME; Hadgraft J; du Plessis J
    J Pharm Pharmacol; 2007 Sep; 59(9):1215-22. PubMed ID: 17883892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermal peptide delivery using colloidal carrier systems.
    Goebel A; Neubert RH
    Skin Pharmacol Physiol; 2008; 21(1):3-9. PubMed ID: 17912018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal drug delivery using microemulsion and aqueous systems: influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems.
    Sintov AC; Botner S
    Int J Pharm; 2006 Mar; 311(1-2):55-62. PubMed ID: 16431047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microemulsions as a surrogate carrier for dermal drug delivery.
    Azeem A; Khan ZI; Aqil M; Ahmad FJ; Khar RK; Talegaonkar S
    Drug Dev Ind Pharm; 2009 May; 35(5):525-47. PubMed ID: 19016057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Skin Retention and Drug Permeation through Intact and Microneedle Pretreated Skin after Application of Propranolol Loaded Microemulsions.
    Kelchen MN; Brogden NK
    Pharm Res; 2018 Oct; 35(12):228. PubMed ID: 30302631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transdermal delivery mechanisms of lecithin nanoparticles with cyclosporin A through mice skin].
    Guo JX; Ping QN; Wu T
    Yao Xue Xue Bao; 2000 Oct; 35(10):782-5. PubMed ID: 11372448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
    Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
    J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrically assisted skin delivery of liposomal estradiol; phospholipid as damage retardant.
    Essa EA; Bonner MC; Barry BW
    J Control Release; 2004 Mar; 95(3):535-46. PubMed ID: 15023464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactively labelled vesicles.
    Fresta M; Puglisi G
    J Drug Target; 1996; 4(2):95-101. PubMed ID: 8894969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of hydrocortisone from liposomal suspensions to the hairless mouse skin following topical application under non-occlusive and occlusive conditions.
    Kim MK; Chung SJ; Lee MH; Shim CK
    J Microencapsul; 1998; 15(1):21-9. PubMed ID: 9463804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organogel-based system for transdermal delivery of propranolol.
    Bhatnagar S; Vyas SP
    J Microencapsul; 1994; 11(4):431-8. PubMed ID: 7931942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomes and skin: from drug delivery to model membranes.
    El Maghraby GM; Barry BW; Williams AC
    Eur J Pharm Sci; 2008 Aug; 34(4-5):203-22. PubMed ID: 18572392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of stability and skin permeation by sucrose stearate and cyclodextrins in progesterone nanoemulsions.
    Klang V; Matsko N; Zimmermann AM; Vojnikovic E; Valenta C
    Int J Pharm; 2010 Jun; 393(1-2):152-60. PubMed ID: 20434531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis.
    Alvi IA; Madan J; Kaushik D; Sardana S; Pandey RS; Ali A
    Anticancer Drugs; 2011 Sep; 22(8):774-82. PubMed ID: 21799471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery.
    Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
    Int J Pharm; 2005 Jul; 298(1):55-67. PubMed ID: 15941634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.